Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Creso looks back on a pivotal year, looks forward to a great 2019
Health & Biotech
Happy animal, happy human: Cannabis products for pets proving a financial hit for Creso
Health & Biotech
Creso Pharma granted a growing licence for its state-of the-art Canadian facility
Health & Biotech
Creso lands cannabis supply deal in Canada just three months after legalisation
Health & Biotech
This partnership could help make medical cannabis big business over the Tasman
Health & Biotech
Creso to expand into Sri Lanka with its medicinal cannabis lozenges
Health & Biotech
Israel votes to start exporting medical cannabis – here’s one ASX listed company that stands to benefit
Health & Biotech
Creso commences international commercialisation of its animal health products with $350K purchase order
Health & Biotech
Creso Pharma makes a play for a dual listing on the Toronto Venture Exchange
Health & Biotech
Creso shakes paws with global animal health pharma to extend its vet product distribution
Health & Biotech
Creso Pharma poised to reach new heights following legalisation of recreational cannabis in Canada
Health & Biotech
Canada legalises pot this week – here are the ASX stocks that could benefit
Escrow Watch
Escrow Watch: 180 million shares could hit the ASX in the next few weeks
Health & Biotech
Creso’s application to become licensed producer of medical cannabis accepted by Health Canada
Health & Biotech